125 related articles for article (PubMed ID: 8946812)
1. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
[TBL] [Abstract][Full Text] [Related]
2. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
[TBL] [Abstract][Full Text] [Related]
3. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty.
Galan KM; Deligonul U; Kern MJ; Chaitman BR; Vandormael MG
Am J Cardiol; 1988 Feb; 61(4):260-3. PubMed ID: 2963518
[TBL] [Abstract][Full Text] [Related]
5. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
6. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
Melkert R; Violaris AG; Serruys PW
J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
[TBL] [Abstract][Full Text] [Related]
7. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
8. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
Foley DP; Melkert R; Serruys PW
Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
[TBL] [Abstract][Full Text] [Related]
10. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
[TBL] [Abstract][Full Text] [Related]
13. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
Schmitz HJ; Erbel R; Meyer J; von Essen R
Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
[TBL] [Abstract][Full Text] [Related]
14. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
[TBL] [Abstract][Full Text] [Related]
15. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
16. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
Faxon DP
J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
[TBL] [Abstract][Full Text] [Related]
17. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for later restenosis after successful coronary angioplasty: Mitsui Memorial Hospital experience].
Tohma M; Yamaguchi T
J Cardiol; 1991; 21(1):43-52. PubMed ID: 1817180
[TBL] [Abstract][Full Text] [Related]
19. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).
DeMaio SJ; King SB; Lembo NJ; Roubin GS; Hearn JA; Bhagavan HN; Sgoutas DS
J Am Coll Nutr; 1992 Feb; 11(1):68-73. PubMed ID: 1541798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
